Graphene Investments Sas Merck & Co., Inc. Transaction History

Graphene Investments Sas

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $271,525 - $295,950	-2,500 Reduced 8.33%	27,500 $3.17 Billion
Q1 2023 May 03, 2023	SELL	$102.94 - $114.86 $288,232 - $321,608	-2,800 Reduced 8.54%	30,000 $3.19 Billion
Q4 2022 Feb 21, 2023	BUY	$87.44 - $112.11 $2.87 Million - $3.68 Million	32,800 New	32,800 $3.64 Billion

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Graphene Investments Sas, based on Form 13F filings with the SEC.

Stay updated on Graphene Investments Sas with notifications on news.